MeVis Medical Solutions (0HI7) AI Stock Analysis

MeVis Medical Solutions

(LSE:0HI7)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Debt-free balance sheetA debt-free structure gives MeVis greater resilience through operating weakness because no interest burden or refinancing schedule competes for cash. Stable equity also preserves flexibility to fund product development, shareholder returns, or strategic investment without relying on additional borrowing.

Negative Factors

Persistent revenue declineThree consecutive annual revenue declines point to a sustained weakening in demand, market reach, or customer expansion rather than a single-period fluctuation. Continued top-line contraction can reduce operating leverage, limit reinvestment capacity, and make future earnings growth harder to restore.

MeVis Medical Solutions (0HI7) vs. iShares MSCI United Kingdom ETF (EWC)

Market Cap: EUR 37.13M
Dividend Yield: 4.68%
Average Volume (3M): 1
Price to Earnings (P/E): 26.8
Beta (1Y): -0.06
Revenue Growth: -6.92%
EPS Growth: -67.82%
Country: UK
Employees: 127
Sector: Healthcare
Sector Strength: 51
Industry: Software - Application

MeVis Medical Solutions Business Overview & Revenue Model

Company Description

MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides...

MeVis Medical Solutions Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

GB:0HI7 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DE:SHL	70Outperform	EUR 47.86B	21.66	12.00%	2.33%	-0.92%	2.06%
DE:EUZ	69Neutral	EUR 832.23M	16.63	19.49%	1.65%	4.42%	35.68%
DE:DRW8	67Neutral	EUR 1.64B	11.28	10.20%	2.93%	5.06%	40.18%
DE:SBS	57Neutral	EUR 273.51M	-562.50	-0.17%	2.67%	―	―
DE:COP	53Neutral	EUR 1.50B	43.42	4.19%	1.74%	―	―
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

* Healthcare Sector Average

Performance Comparison

GB:0HI7 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
GB:0HI7	MeVis Medical Solutions	22.00	-1.32	-5.64%
DE:COP	CompuGroup Medical	28.45	4.30	17.83%
DE:DRW8	Draegerwerk AG & Co. KGaA (0MT8)	75.40	15.88	26.67%
DE:EUZ	Eckert & Ziegler Strahlen und Medizintechnik	13.30	-3.09	-18.88%
DE:SBS	STRATEC Biomedical	22.50	0.32	1.43%
DE:SHL	Siemens Healthineers	42.89	-4.78	-10.03%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

MeVis Medical Solutions AI Stock Analysis